Literature DB >> 29435304

Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.

Gholamreza Khamisipour1,2, Elham Mansourabadi3, Behrouz Naeimi4, Ali Moazzeni1, Rahim Tahmasebi2, Mojtaba Hasanpour2, Majid Mosahebi Mohammadi5, Zahra Mansourabadi1, Shakib Shamsian2.   

Abstract

MicroRNA (miR), as non-coding small RNA, are key regulators of cancer-related biological cell processes and contribute to tumor growth through regulation of groups of pro- and anti-apoptotic genes. The present study aimed to investigate the effects of miR-29a on the expression of genes involved in apoptosis, including p21, B-cell lymphoma 2 (BCL-2), p53 and survivin. The MCF-7 breast cancer cell line was transfected with anti-miR-29a and treated with Taxol in subdivided treatment groups including: Scramble; anti-miR-29a; anti-miR-29a + Taxol; Taxol; and control. Expression levels of p21, BCL-2, p53 and survivin were evaluated using reverse transcription-quantitative polymerase chain reaction. miR-29a knockdown resulted in p21 and p53 upregulation and a decrease in survivin expression. These results indicated that miR-29a inhibition regulates apoptosis. The present data suggested that miR-29a inhibition may be a promising strategy for the induction of apoptosis of tumor cells.

Entities:  

Keywords:  MCF-7; Taxol; apoptosis; breast carcinoma; microRNA-29a

Year:  2017        PMID: 29435304      PMCID: PMC5776418          DOI: 10.3892/mco.2017.1528

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  38 in total

Review 1.  The evolution of gene regulation by transcription factors and microRNAs.

Authors:  Kevin Chen; Nikolaus Rajewsky
Journal:  Nat Rev Genet       Date:  2007-02       Impact factor: 53.242

2.  Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent.

Authors:  R Ofir; R Seidman; T Rabinski; M Krup; V Yavelsky; Y Weinstein; M Wolfson
Journal:  Cell Death Differ       Date:  2002-06       Impact factor: 15.828

3.  Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome.

Authors:  Kerry M Bauer; Amanda B Hummon
Journal:  J Proteome Res       Date:  2012-08-27       Impact factor: 4.466

Review 4.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

Review 5.  Diverse roles of miR-29 in cancer (review).

Authors:  Hesong Jiang; Guang Zhang; Jun-Hua Wu; Chun-Ping Jiang
Journal:  Oncol Rep       Date:  2014-02-20       Impact factor: 3.906

Review 6.  Awakening guardian angels: drugging the p53 pathway.

Authors:  Christopher J Brown; Sonia Lain; Chandra S Verma; Alan R Fersht; David P Lane
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

Review 7.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

8.  p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

Authors:  Guido T Bommer; Isabelle Gerin; Ying Feng; Andrew J Kaczorowski; Rork Kuick; Robert E Love; Yali Zhai; Thomas J Giordano; Zhaohui S Qin; Bethany B Moore; Ormond A MacDougald; Kathleen R Cho; Eric R Fearon
Journal:  Curr Biol       Date:  2007-07-26       Impact factor: 10.834

9.  The inhibitory role of Mir-29 in growth of breast cancer cells.

Authors:  Zhenglong Wu; Xiaona Huang; Xing Huang; Qiang Zou; Yujiang Guo
Journal:  J Exp Clin Cancer Res       Date:  2013-12-01

10.  Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells.

Authors:  Encieh Choghaei; Gholamreza Khamisipour; Mojtaba Falahati; Behrooz Naeimi; Majid Mossahebi-Mohammadi; Rahim Tahmasebi; Mojtaba Hasanpour; Shakib Shamsian; Zahra Sadat Hashemi
Journal:  Oncol Res       Date:  2016-01-21       Impact factor: 5.574

View more
  3 in total

1.  Therapeutic potential of anti-miR29a in breast cancer patients with type 2 diabetes: an in vitro and xenograft mouse-model study.

Authors:  Zhihua Li; Liangliang Min; Lu Chen; Yangyang Hu; Wenjing Luan; Cong Li; Qiuyun Xiong; Kedi Huang
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

2.  Overexpression of MiR-506 in Jurkat (Acute T Cell Leukemia) Cell Line.

Authors:  Shaghayegh Rostami Yasuj; Narges Obeidi; Gholamreza Khamisipou; Zeynab Gharehdaghi; Zivar Zangeneh
Journal:  Iran J Pathol       Date:  2020-07-16

3.  Hypoxia-induced apoptosis of cardiomyocytes is restricted by ginkgolide B-downregulated microRNA-29.

Authors:  Dezhi Ren; Fang Li; An Gao; Qingwen Cao; Yarong Liu; Junru Zhang
Journal:  Cell Cycle       Date:  2020-04-16       Impact factor: 4.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.